Jun 24 |
Repligen (RGEN) Soars 4.4%: Is Further Upside Left in the Stock?
|
May 22 |
Industry Analysts Just Upgraded Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecasts By 16%
|
May 10 |
The Analyst Landscape: 7 Takes On AnaptysBio
|
May 2 |
AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
May 1 |
AnaptysBio (ANAB) Soars 14.3%: Is Further Upside Left in the Stock?
|
Apr 24 |
Actym Therapeutics Appoints Thomas Smart as CEO
|
Apr 15 |
BTIG Research Predicts Over 118% Rally for These 3 Stocks
|
Apr 9 |
Why You Shouldn't Bet Against AnaptysBio (ANAB) Stock.
|
Mar 18 |
Industry Analysts Just Made A Stunning Upgrade To Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecasts
|
Mar 14 |
What Makes AnaptysBio, Inc. (ANAB) a New Buy Stock
|